Outbreak of metallo-b-lactamase VIM-2-positive strains of pseudomonas aeruginosa in the ivory coast

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 12, 2013, Pages 2952-2954

  Jeannot, Katy ^a   Guessennd, Nathalie ^b   Fournier, Damien ^a   Müller, Emeline ^a   Gbonon, Valèrie ^b   Plèsiat, Patrick ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Centre National de Référence aux antibiotiques de Côted'Ivoire   (Côte d’Ivoire)

Author keywords

Carbapenemases; Imipenem resistance; P. aeruginosa

Indexed keywords

ACYLTRANSFERASE; AMIKACIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; DIHYDROFOLATE REDUCTASE; DORIPENEM; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; TOBRAMYCIN; TRIMETHOPRIM; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAM; BETA LACTAMASE; CARBAPENEMASE; VIM 2 BETA LACTAMASE; VIM-2 BETA-LACTAMASE;

ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; COTE D'IVOIRE; DNA SEQUENCE; INTEGRON; INTENSIVE CARE UNIT; LETTER; LUNG INFECTION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA; TANDEM REPEAT; TEACHING HOSPITAL; URINARY TRACT INFECTION; VIM 2 GENE; CHEMISTRY; ENZYMOLOGY; EPIDEMIC; GENE ORDER; GENETICS; HUMAN; IMIPENEM RESISTANCE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR GENETICS; PSEUDOMONAS INFECTION; SECRETION (PROCESS);

CARBAPENEMASES; IMIPENEM RESISTANCE; P. AERUGINOSA;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; COTE D'IVOIRE; DISEASE OUTBREAKS; DNA, BACTERIAL; GENE ORDER; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEQUENCE ANALYSIS, DNA;

EID: 84887531088     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt296     Document Type: Letter

References (10)

1. Cornaglia G, Giamarellou H, Rossolini GM. Metallo-b-lactamases: a last frontier for b-lactams? Lancet Infect Dis 2011; 11: 381-93.
2. Pollini S, Maradei S, Pecile P et al. FIM-1, a new acquired metallob- lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 2013; 57: 410-6.
3. Poirel L, Naas T, Nicolas D et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-b-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 2000; 44: 891-7.
4. Hammani S, Gautier V, Ghozzi R et al. Diversity in VIM-2-encoding class 1 integrons and occasional blaSHV2a carriage in isolates of a persistent, multidrug-resistant Pseudomonas aeruginosa clone from Tunis. Clin Microbiol Infect 2010; 16: 189-93.
5. Touati M, Diene SM, Dekhil M et al. Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria. Antimicrob Agents Chemother 2013; 57: 2426-7.
6. Jacobson RK, Minenza N, Nicol M et al. VIM-2 metallob- lactamase-producing Pseudomonas aeruginosa causing an outbreak in South Africa. J Antimicrob Chemother 2012; 67: 1797-8.
7. Pitout JD, Revathi G, Chow BL et al. Metallo-b-lactamase-producing Pseudomonas aeruginosa isolated from a large tertiary centre in Kenya. Clin Microbiol Infect 2008; 14: 755-9.
8. Vu-Thien H, Corbineau G, Hormigos K et al. Multiple-locus variablenumber tandem-repeat analysis for longitudinal survey of sources of Pseudomonas aeruginosa infection in cystic fibrosis patients. J Clin Microbiol 2007; 45: 3175-83.
9. Samuelsen O, Buaro L, Toleman MA et al. The firstmetallo-b-lactamase identified in Norway is associated with a TniC-like transposon in a Pseudomonas aeruginosa isolate of sequence type 233 imported from Ghana. Antimicrob Agents Chemother 2009; 53: 331-2.
10. Lolans K, Queenan AM, Bush K et al. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-blactamase (VIM-2) in the United States. Antimicrob Agents Chemother 2005; 49: 3538-40.